five

Comorbidities and respiratory medications in the total COPD cohort (at study start) further split by the MRC dyspnoea grade (first recorded from study start).

收藏
NIAID Data Ecosystem2026-03-08 收录
下载链接:
https://figshare.com/articles/dataset/_Comorbidities_and_respiratory_medications_in_the_total_COPD_cohort_at_study_start_further_split_by_the_MRC_dyspnoea_grade_first_recorded_from_study_start_/899268
下载链接
链接失效反馈
官方服务:
资源简介:
Percentages are based on row total. Comorbidities were searched for any time in the history before the observation period start; respiratory medications were searched for 12 months prior to study start. MRC scoring 1–5 equals to mMRC grades 0–4 with MRC 1 equals to mMRC 0. a≥4 treatments per year. Abbreviations: COPD, chronic obstructive pulmonary disease; ICS, inhaled corticosteroids; LABA, long-acting beta-blockers; LAMA, long-acting anticholinergics; MI, myocardial infarction; MRC, Medical Research Council; SABD, short-acting bronchodilators; SD, standard deviation.
创建时间:
2014-01-10
二维码
社区交流群
二维码
科研交流群
商业服务